Targeted prostate cancer treatment cuts risk of side effects, study suggests

An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.

This newsroom brief was automatically prepared from a monitored public feed and rewritten as a concise summary for readers.

Source attribution: BBC Health. Read the original report at https://www.bbc.co.uk/news/articles/cwyq3lnndvxo?at_medium=RSS&at_campaign=rss